NCT07367074

Brief Summary

This study aims to evaluate the effect of an educational intervention on sexual function and therapeutic adherence among women with breast cancer followed in the medical oncology department of Ibn Tofail Hospital, affiliated with Mohammed VI University Hospital Center in Marrakech. Participants will receive a structured therapeutic education program focusing on breast cancer, available treatments and their potential side effects, as well as treatment adherence and its prognostic significance. Educational sessions will be complemented by patient follow-up to reinforce key messages and support adherence. The study will assess changes in sexual function and therapeutic adherence before and after the educational intervention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 26, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

January 26, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 3, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

January 17, 2026

Last Update Submit

February 28, 2026

Conditions

Keywords

Breast cancerEducational interventionSexual functionTherapeutic adherence

Outcome Measures

Primary Outcomes (1)

  • Change in Sexual Function Score (FSFI)

    Sexual function will be assessed using the Female Sexual Function Index (FSFI), a validated questionnaire with a total score ranging from 2 to 36, where higher scores indicate better sexual function. The primary outcome will be the change in the total FSFI score between baseline and two months after the educational intervention.

    Baseline and 2 months after the intervention

Secondary Outcomes (1)

  • Change in Therapeutic Adherence Score (ARMS-12)

    Baseline and 2 months after the intervention

Study Arms (1)

Educational Intervention Arm

EXPERIMENTAL

Participants assigned to this arm will receive a structured educational intervention focusing on breast cancer, treatment-related side effects, sexual health, and therapeutic adherence. The intervention consists of two educational sessions of two hours each, followed by follow-up support via WhatsApp. Outcomes will be assessed before the intervention and two months after its implementation.

Behavioral: Therapeutic Education Program for Women With Breast Cancer

Interventions

This intervention will consist of a structured therapeutic education program designed for women with breast cancer. The program will focus on disease-related information, treatment modalities and their associated side effects, sexual function, and strategies to improve therapeutic adherence. The intervention will include two face-to-face educational sessions, each lasting two hours, delivered by a midwife enrolled in the final semester of a Master's program in advanced practices in oncology and Palliatives Cares, followed by supportive follow-up via WhatsApp to reinforce key messages and address participants' concerns. The educational content will be adapted to participants' needs and health literacy levels. Outcomes related to sexual function and treatment adherence will be assessed before the intervention and two months after its implementation.

Educational Intervention Arm

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study will be restricted to women diagnosed with breast cancer.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged 18 years and older.
  • Diagnosed with breast cancer.
  • Receiving oral anticancer treatment.
  • Willing to participate in the study.
  • Able to attend the educational sessions.
  • Having access to a mobile phone (smartphone).

You may not qualify if:

  • Women with communication disorders.
  • Women with severe psychiatric disorders that will interfere with participation in the educational intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Oncology Department, Ibn Tofail Hospital, Mohammed VI University Hospital Center

Marrakesh, Marrakech-Safi, Morocco

RECRUITING

MeSH Terms

Conditions

Breast NeoplasmsTreatment Adherence and Compliance

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesHealth BehaviorBehavior

Central Study Contacts

Safa LAAMARI, Master Student

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: This is a single-group interventional study with a pre-post design, in which all participants receive the same educational intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Master's student in advanced practices in oncology and palliative care

Study Record Dates

First Submitted

January 17, 2026

First Posted

January 26, 2026

Study Start

January 26, 2026

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

March 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations